UnknownNot Applicable

Vienna Vascular Liver Disease Study

Austria200 participantsStarted 2017-12-12

Plain-language summary

The aim of this Register Trial is to systematically study the epidemiology, risk factors, liver function as well prognosis of patients with vascular liver diseases. Furthermore, important clinical parameters will be assessed in order to evaluate patients' coagulation status and in order to develop new biomarkers derived from blood, urine, stool or ascites of patients as well as histological samples from the upper / lower GI-tract or the liver in order to better understand the natural history of vascular liver diseases.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of a vascular liver disease by imaging (sonography, CT, MRI), transient elastography or liver histology * PVT: Portal vein thrombosis * NCPH: non-cirrhotic Portal Hypertension * PSVD: porto-sinusoidal vascular disorder * BCS: Budd-Chiari-Syndrome * SOS: sinusoidal occlusive disease * HHT: hereditary hemorrhagic teleangiectasia * CIRCAD: cirrhosis cardiaque * Age \>18 years and \<100 years * Written informed consent obtained Exclusion Criteria: \- withdrawal of written informed consent

What they're measuring

Hepatic Decompensation

Timeframe: Up to 10 years (=Study Period)

Trial details

NCT IDNCT03541057

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

Contact for this trial

Thomas Reiberger, MD

0043140400 thomas.reiberger@meduniwien.ac.at

View on ClinicalTrials.gov More Vascular Liver Disease trials